Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Van Tu

Physician Assistant Bethpage, NY Physician Assistant

NPI 1295119329 CMS profile 10482975

72 Roosevelt Dr, Bethpage, NY 11714

Open in the dashboard

General payments

$7,254

450 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Van Tu of Bethpage, NY is reported in the CMS Open Payments database as having received $7,254 across 450 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 95th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,795 116
2024 General $1,824 112
2023 General $1,962 124
2022 General $1,049 62
2021 General $625 36

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Van Tu
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Van Tu were reported at $1,795. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Van Tu Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $625 $132 $37–$438 $132
2022 $1,049 $155 $48–$522 $149
2023 $1,962 $167 $52–$557 $160
2024 $1,824 $178 $55–$600 $164
2025 $1,795 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Janssen Biotech, Inc. $1,711 87 payments
  2. LEO Pharma Inc. $1,536 103 payments
  3. AbbVie, Inc. $967 65 payments
  4. Novartis Pharmaceuticals Corporation $720 51 payments
  5. UCB, Inc. $637 47 payments
  6. E.R. Squibb & Sons, L.L.C. $610 45 payments
  7. Lilly USA, LLC $517 24 payments
  8. Sun Pharmaceutical Industries Inc. $135 5 payments
  9. Galderma Laboratories, L.P. $106 6 payments
  10. Amgen Inc. $75 3 payments
  11. Other $241 14 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $6,880 445 payments
  2. Education $374 5 payments
Products named General payments · program years 2021–2025
  1. TREMFYA $1,656 84 payments
  2. ADBRY $1,460 97 payments
  3. SKYRIZI Immunology $621 40 payments
  4. SOTYKTU $610 45 payments
  5. TALTZ $489 23 payments
  6. Bimzelx $482 33 payments
  7. COSENTYX Dermatology $446 34 payments
  8. COSENTYX Immunology $235 14 payments
  9. SKYRIZI Immunology $205 11 payments
  10. OLUMIANT $199 9 payments
  11. Other $1,232 80 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

450 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record